Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier?

Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure-volume loop analysis

(2010) Martin Penicka et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy

(2010) Eugene S. Chung et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials

(2010) Steven A. Lubitz et al.   EUROPEAN JOURNAL OF HEART FAILURE

The European cardiac resynchronization therapy survey

(2009) K. Dickstein et al.   EUROPEAN HEART JOURNAL

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008

(2009) Dirk J. van Veldhuisen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization Therapy

(2009) ALEXANDER H. MAASS et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Heart Failure With Normal Left Ventricular Ejection Fraction: What is the Evidence?

(2009) Michael Kindermann et al.   TRENDS IN CARDIOVASCULAR MEDICINE

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study

(2007) J G F Cleland et al.   HEART